Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
208
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Journal of Research in Ayurvedic Sciences
2022
July- September
;
6
(3)
:101-108
A clinical study to evaluate the efficacy of Ayurvedic intervention in management of chronic bronchitis
Rinku Tomar (1)
,
Rinku Tomar (1)
,
Babita Yadav (1)
,
Babita Yadav (1)
,
Harbans Singh (1)
,
Harbans Singh (1)
,
Amin Hetalben (1)
,
Amin Hetalben (1)
,
Shruti Khanduri (1)
,
Shruti Khanduri (1)
,
Bhagwan Sahay Sharma (1)
,
Bhagwan Sahay Sharma (1)
,
Rakesh Rana (1)
,
Rakesh Rana (1)
,
Richa Singhal (1)
,
Richa Singhal (1)
,
Bhogavalli Chandrasekhararao (2)
,
Bhogavalli Chandrasekhararao (2)
,
Narayanam Srikanth (2)
,
Narayanam Srikanth (2)
,
Kartar Singh Dhiman (1)
,
Kartar Singh Dhiman (1)
1. Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Govt. of India, New Delhi, India 2. Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Govt. of India, New Delhi, India
Abstract
INTRODUCTION: Talisadi Churna (TC) is an Ayurveda formulation indicated in managing Kaphaja Kasa. The symptoms of Kaphaja Kasa, narrated in the Ayurveda classical texts, resembles with chronic bronchitis (CB). This open-label, single-arm, prospective study was planned to evaluate the efficacy of TC in the management of CB. MATERIALS AND METHODS: Seventy-five patients who fulfilled the inclusion criteria for CB were enrolled at Central Ayurveda Research Institute for Respiratory Disorders, Patiala. They were treated by oral administration of TC 3 gm thrice a day for 12 weeks with a post-treatment follow-up after four weeks. The results were assessed by change in Leicester Cough Questionnaire (LCQ) Score, episodes of acute exacerbation, change in St. George’s Respiratory Questionnaire (SGRQ) Score for Quality-of-life, Functional/Exercise capacity [change in peak expiratory flow rate (PEFR) and FEV1%] and occurrence of adverse events. RESULTS: Sixty-eight participants completed the study. Significant results (P < 0.001) is found in wheezing, nausea, etc and in the cardinal symptoms such as breathlessness, cough, and expectoration. Statistically significant changes were found in LCQ, SGRQ, and PEFR parameters. No adverse events were reported during the study period. CONCLUSION: Talisadi Churna may be found effective in conditions such as Chronic Bronchitis. Based on the promising results of this study, randomized controlled trials with adequate sample size may be planned on Talisadi Churna in Chronic Bronchitis compared to standard care or as an add-on therapy with conventional medicine. Therefore TC can be further evaluated for incorporating it under the standard measure for management of CB. Keywords: Chronic bronchitis, Kaphaja Kasa, Talisadi Churna
DHARA ID:
D060674
Link To Full Paper
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi